The Prostate

Cover image for Vol. 71 Issue 15

November 2011

Volume 71, Issue 15

Pages 1595–1709

  1. Original Articles

    1. Top of page
    2. Original Articles
    1. Enzymatically active prostate-specific antigen promotes growth of human prostate cancers (pages 1595–1607)

      Simon A. Williams, Christine A. Jelinek, Ivan Litvinov, Robert J. Cotter, John T. Isaacs and Samuel R. Denmeade

      Version of Record online: 10 MAR 2011 | DOI: 10.1002/pros.21375

    2. The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen Deprivation (pages 1608–1615)

      Daniel Keizman, Peng Huang, Emmanuel S. Antonarakis, Victoria Sinibaldi, Michael A. Carducci, Samuel Denmeade, Jenny J. Kim, Janet Walczak and Mario A. Eisenberger

      Version of Record online: 22 MAR 2011 | DOI: 10.1002/pros.21377

    3. The 17th Annual Prostate Cancer Foundation scientific retreat: Meeting report (pages 1616–1620)

      Katrin Rhodes Ericson, Jonathan W. Simons and Howard R. Soule

      Version of Record online: 10 MAR 2011 | DOI: 10.1002/pros.21378

    4. Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer (pages 1621–1630)

      Sachin Bhusari, Bing Yang, Jessica Kueck, Wei Huang and David F. Jarrard

      Version of Record online: 22 MAR 2011 | DOI: 10.1002/pros.21379

    5. The effect of demographic and clinical factors on the relationship between BMI and PSA levels (pages 1631–1637)

      Jonathan L. Wright, Daniel W. Lin and Janet L. Stanford

      Version of Record online: 22 MAR 2011 | DOI: 10.1002/pros.21380

    6. Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer (pages 1638–1645)

      Po Yee Yip, James G. Kench, Krishan K. Rasiah, Ruth Pe Benito, C.-Soon Lee, Phillip D. Stricker, Susan M. Henshall, Robert L. Sutherland and Lisa G. Horvath

      Version of Record online: 22 MAR 2011 | DOI: 10.1002/pros.21381

    7. The calcium sensor STIM1 is regulated by androgens in prostate stromal cells (pages 1646–1655)

      Paul A. Berry, Richard Birnie, Alastair P. Droop, Norman J. Maitland and Anne T. Collins

      Version of Record online: 22 MAR 2011 | DOI: 10.1002/pros.21384

    8. PC3 is a cell line characteristic of prostatic small cell carcinoma (pages 1668–1679)

      Sheng Tai, Yin Sun, Jill M. Squires, Hong Zhang, William K. Oh, Chao-Zhao Liang and Jiaoti Huang

      Version of Record online: 22 MAR 2011 | DOI: 10.1002/pros.21383

    9. Enzymatic activity of free-prostate-specific antigen (f-PSA) is not required for some of its physiological activities (pages 1680–1690)

      Kailash C. Chadha, Bindukumar B. Nair, Srikant Chakravarthi, Rita Zhou, Alejandro Godoy, James L. Mohler, Ravikumar Aalinkeel, Stanley A. Schwartz and Gary J. Smith

      Version of Record online: 28 MAR 2011 | DOI: 10.1002/pros.21385

    10. FGFR1 abrogates inhibitory effect of androgen receptor concurrent with induction of androgen-receptor variants in androgen receptor-negative prostate tumor epithelial cells (pages 1691–1700)

      Masashi Kobayashi, Yanqing Huang, Chengliu Jin, Yongde Luo, Tetsuji Okamoto, Fen Wang and Wallace L. McKeehan

      Version of Record online: 28 MAR 2011 | DOI: 10.1002/pros.21386

    11. Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia (pages 1701–1709)

      Grégoire Robert, Frank Smit, Daphne Hessels, Sander Jannink, Herbert F.M. Karthaus, Tilly Aalders, Kees Jansen, Alexandre de la Taille, Peter F. Mulders and Jack A. Schalken

      Version of Record online: 28 MAR 2011 | DOI: 10.1002/pros.21387

SEARCH

SEARCH BY CITATION